FDA approves AZ’s Baxfendy (baxdrostat), first-in-class ASI for uncontrolled hypertension
Baxfendy 2mg lowered systolic blood pressure by 15.7 mmHg (9.8 mmHg placebo-adjusted) from baseline in BaxHTN trial.
AstraZeneca
AstraZeneca launches the first FDA-approved influenza vaccine available for home use
Offers a convenient, household-based option for seasonal flu vaccination.